CClinicalTrials.gg
CompletedNCT04972500Updated Nov 8, 2021

The Influence of Fasting on Selected Hemodynamic Parameters Measured in a Non-invasive Way

An interventional study of Nutricia Pre-op, 400 milliliters, per os in Perioperative Complication and Hemodynamic Instability, sponsored by Medical University of Gdansk. Completed at 1 site in Poland. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-11-08.

Sponsored by Medical University of Gdansk · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Preoperative fasting is considered to be refraining from taking meals for at least 6 hours and clear fluids for at least 2 hours before anesthesia. On the one hand, it is a procedure that reduces the risk of aspiration of chyme and the occurrence of Mendelson's syndrome, and on the other hand, it is one of the causes of water and carbohydrate disturbances in patients undergoing general anesthesia. Most of them experience some degree of dehydration in the preoperative period. It is associated with a worse prognosis. Due to the negative impact of fasting on homeostasis, as well as significant changes in heart rate in participants in the previous study, we decided to measure the hemodynamic parameters during fasting. The development of impedance cardiography techniques enables the measurement of these parameters by a non-invasive method.

After obtaining the participant's written consent to participate in the study, the first measurement of body weight, blood pressure using a non-invasive method and hemodynamic parameters using a non-invasive impedance cardiography method using the Niccomo ™ device (Medizinische Messtechnik GmbH) will be performed in the evening. The subject will then be asked to refrain from food for at least 10 hours and fluid for 6 hours before the next measurement. The next morning, another measurement will be made and the participant will be randomly assigned to one of two groups: subjects in the first group will be asked to refrain from eating and drinking for another 2 hours, while subjects in the second group per os will receive 400 milliliters of PreOp® (Nutricia ™ preparation intended for preoperative dietary management in surgical patients, containing carbohydrates and electrolytes). After another two hours, the third measurement of the tested parameters will be performed. The obtained results will be subjected to statistical analysis consisting in comparing the values of hemodynamic parameters between the studied groups at appropriate measurement points.

02

Conditions studied

  • Perioperative Complication
  • Hemodynamic Instability
03

In context

Lead sponsor

Medical University of Gdansk is the lead sponsor of 130 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • American Society of Anesthesiology (ASA) general condition assessment 1 or 2

Exclusion criteria

Exclusion Criteria:

  • Chronic kidney disease
  • Circulatory failure
  • Lung diseases
  • Diseases of the heart valves
  • History of hypoglycaemic episodes or any carbohydrate disturbance.
  • Height less than 120 cm or greater than 230 cm
  • Body weight less than 30 kg or greater than 155 kg.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Pre-op

    Nutricia Pre-op, 400 milliliters, per os

    Dietary Supplement: Nutricia Pre-op, 400 milliliters, per os

  • No intervention
    Control

    No intervention

Interventions

  • Dietary supplementNutricia Pre-op, 400 milliliters, per os

    After 10 hours of fasting participants will receive per os 400 milliliters of Nutricia Pre-op

06

What researchers measure

Primary outcomes

  1. Changes in cardiac index (CI)

    Cardiac index will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device. Cardiac index will be measured in l/min/m\^2 (liters per minute per square meter).

    Time frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration

  2. Changes in systemic vascular resistance index (SVRI)

    Systemic vascular resistance index will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device. Systemic vascular resistance index will be measured in dyn\*s\*cm\^-5\*m\^2 (dyne multiply by second multiply by centimeters to the power of minus 5 multiply by square meter)

    Time frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration

  3. Changes in stroke volume (SV)

    Stroke volume will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device. Stroke volume will be measured in mL (milliliters).

    Time frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration

  4. Changes in heart rate (HR)

    Heart rate will be measured non-invasively with Niccomo™(Medizinische Messtechnik GmbH) device. Heart rate will be measured in 1/min (beats per minute).

    Time frame: Changes form baseline after 10 hours of fasting and after 2 hours of pre-op administration

07

Study locations

1 site
  • Medical University of Gdansk - Departament of Anesthesiology and Intensive Care
    Gdańsk, Pomorskie 80-210, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04972500
Lead sponsor
Medical University of Gdansk
Responsible party
Radosław Owczuk (Clinical Professor, Head of Department of Anaesthesiology and Intensive Care, Medical University of Gdansk) — Principal investigator
First posted
Jul 22, 2021
Start date
Jul 12, 2021
Primary completion
Nov 4, 2021
Completion
Nov 4, 2021
Last update
Nov 8, 2021

Study contacts

Radoslaw Owczuk, Prof.
principal investigator · Medical University of Gdansk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion